- cafead Apr 08, 2022 at 11:02: AM
via BioCryst is taking a beating Friday morning after reporting it would pause enrollment in three studies for its lead pipeline program.
In a terse statement put out right before the market opened, the Durham, NC-based biotech said it discovered elevated serum creatinine levels in some patients, and will halt recruitment while it investigates. Elevated creatine levels can be a sign of kidney dysfunction.
article source
In a terse statement put out right before the market opened, the Durham, NC-based biotech said it discovered elevated serum creatinine levels in some patients, and will halt recruitment while it investigates. Elevated creatine levels can be a sign of kidney dysfunction.
article source